ÂÜÀòÂÒÂ×

Anjili Mathur has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as Chief of Staff and Director of Immunology Strategic Management at AbbVie since December 2021. Prior to AbbVie, Anjili held the position of Senior Director and Head of Portfolio Strategy at Werewolf Therapeutics from November 2019 to November 2021. Anjili's career began at Curis as a Research Scientist and progressed through various roles at Merck and AstraZeneca, where responsibilities included immuno-oncology diagnostics marketing and oncology access strategy. Anjili holds multiple graduate certificates in marketing strategy, business strategy, and intellectual property law from Cornell University and Northeastern University, along with a Bachelor's degree in Honours Biology from McMaster University.